CEbiotech.com - Central European Biotechnology Portal
be visible on the BioBusiness market                  ISSN 2300-0228
Most popular
searches

All articles

/ 2
Filters:
Show search box
2013-01-24
 New Novo Nordisk diabetes drugs gain EC approval

New Novo Nordisk diabetes drugs gain EC approval

Novo Nordisk drugs for the treatment of diabetes in adults - Tresiba® (insulin degludec) and Ryzodeg® (insulin degludec/insulin aspart), has been granted European Commission’s approval across all EU member states.... Read more
Tags medicine , pharma , europe
2013-01-08 to 2013-01-09
Will Adamed win against cancers? Part II of the interview with Dr Jerzy Pieczykolan about 3

Will Adamed win against cancers? Part II of the interview with Dr Jerzy Pieczykolan about 3-CLA project

Adamed is a Polish pharmaceutical and biotech company focused on the next generation drug development and production. For over 25 years, the company has been providing pharmaceuticals to patients suffering from cardiology, pulmonology, gastroenterology, gynaecology, diseases of the central nervous sy... Read more
Tags biotechnology , poland , medicine , pharma , interview
Will Adamed Group win against cancers? Part I of the interview with Dr Jerzy Pieczykolan ab

Will Adamed Group win against cancers? Part I of the interview with Dr Jerzy Pieczykolan about 3-CLA project

Adamed is a Polish pharmaceutical and biotech company focused on the next generation drug development and production. For over 25 years, the company has been providing pharmaceuticals to patients suffering from cardiology, pulmonology, gastroenterology, gynaecology, diseases of the central nervous sy... Read more
Tags biotechnology , poland , medicine , pharma , interview
2012-11-30
Prix Galien - first time in Poland!

Prix Galien - first time in Poland!

The first edition of prestigious Prix Galien Poland 2012 contest was closed on the 20th November of 2012. The awards are being given to the most groundbreaking and innovative solutions in the field of medicine and pharma for more than 40 years. Five gold medals were given away during the glamorous ce... Read more
Tags poland , medicine , events , pharma
2012-10-10
Mabion starts clinical trials in Serbia

Mabion starts clinical trials in Serbia

Mabion SA – polish biotech company – submitted to the Serbian Ministry of Health all the scientific and legal documentation required to register the clinical trials of MabionCD20 – a drug that is to be used in blood cancer and rheumatoid arthritis treatment. Serbia is the second of all 8 selected Eur... Read more
Tags biotechnology , poland , medicine , europe
2012-08-14
 Euroimplant S.A. serves new solutions for regenerative medicine and cosmetics

Euroimplant S.A. serves new solutions for regenerative medicine and cosmetics

Euroimplant S. A. has recently gained a patent concerning their newest inventions – the “Bioreaktor”. The invention is adjusted to tissue engineering (e.g. 3D cell culture) and in vivo toxicology as well as many other biotechnological applications.... Read more
Tags biotechnology , poland , medicine
2012-05-14 to 2012-05-15
Directed therapy of Cushing’s disease finally available!

Directed therapy of Cushing’s disease finally available!

We have approached another medical breakthrough: EU has approved the latest Novartis drug – Signifor® – the first pharmaceutical to treat patients with Cushing’s disease. ... Read more
Tags medicine , pharma
Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commercialization

Curetis AG Achieves CE-Marking for Unyvero™ Solution and Initiates Commercialization

Successful completion of performance evaluation study; CE Mark for Unyvero™ instrument system and pneumonia application... Read more
Tags medicine , pharma
2012-05-07
 How to market the technology to fit the XXI century needs of Molecular Diagnostics

How to market the technology to fit the XXI century needs of Molecular Diagnostics

Molecular diagnostics assess biological makeup at the genetic level. Unlocking DNA code can reveal variations between individuals which may represent a predisposition to develop a disease or even treatment options that may be more effective in some people. To be precise it could be said that molecul... Read more
Tags bioforum , biotechnology , medicine
2012-04-26
2012-04-16
 Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models

Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models

Despite the dramatic growth in the number and power of molecular diagnostic technologies, the increasing clinical and economic value of the tests derived from them, and the therapeutic power of the drugs whose use can and should be guided by those tests, the reimbursement system for diagnostic tests ... Read more
Tags bioforum , medicine , pharma
2012-04-09 to 2012-04-12
 Aleva Neurotherapeutics Raises CHF 4.0 Million in Series B Financing Round

Aleva Neurotherapeutics Raises CHF 4.0 Million in Series B Financing Round

Lead investor Banexi Ventures Partners joins strong investment consortium... Read more
Tags medicine , pharma
Clinical Trials in Central and Eastern Europe become the global advantage

Clinical Trials in Central and Eastern Europe become the global advantage

Newly developed drugs must be controlled in terms of efficiency and safety. At this step clinical trials are inevitable. They account for the biggest and also the longest part of total cost connected with introduction of new pharmaceuticals to the market. It is estimated that the global market of cli... Read more
Tags medicine , pharma , interview , russia
2012-04-02
Emerging Regenerative Medicine Firm in Czech Republic Chooses CellBase CT

Emerging Regenerative Medicine Firm in Czech Republic Chooses CellBase CT

To Improve Reproducibility and Affordability of their Autologous Cell Therapies... Read more
Tags biotechnology , czech republic , medicine
2012-03-12 to 2012-03-13
Prix Galien - finally in Poland! World-class contest promoting innovative developments in p

Prix Galien - finally in Poland! World-class contest promoting innovative developments in pharmacy and medicine

In 2012, for the first time, Poland will be the host of the first edition of the prestigious Prix Galien international contest, which for more than 40 years has been rewarding the greatest breakthroughs in pharmacy and medicine. The award enjoys the highest recognition and is treated as the equivalen... Read more
Tags medicine , events , pharma
Treatment tailored to the patient – the world of personalized medicine

Treatment tailored to the patient – the world of personalized medicine

We are all alike – one could say when it comes to general features of people all around the world. Our general appearance, physical and psychological needs are very similar. Yet, “similar” does not mean “the same”. This fact is particularly important in terms of healthcare, where the issue of differe... Read more
Tags medicine , pharma
2012-02-17
Cormay co. awarded as the most successful and the most prospective company 2011

Cormay co. awarded as the most successful and the most prospective company 2011

Cormay co. was granted for the greatest success and the best future perspectives among other co-partnerships in “The Best Co-partnership in the Stock Market” plebiscite. Today it is one of the most dynamically developing Polish companies dealing with molecular diagnostics. Its fast expansion in forei... Read more
Tags poland , medicine